Vascular experts establish appropriate use of IVUS in peripheral interventions
Use of IVUS recommended in all phases of lower extremity arterial and venous revascularization procedures to guide clinical decisions
Use of IVUS recommended in all phases of lower extremity arterial and venous revascularization procedures to guide clinical decisions
The company will strengthen its position in the ‘green solvent’ market by increasing its capacity by 20% to 120,000 MTPA from 100,000 MTPA before the end of current fiscal
The domestic business has registered a single-digit growth on the huge base of last year and this was driven by robust demand across established therapies and brands
Aarti Drugs Limited has reported total income of Rs. 622.22 crores during the quarter ended June 30, 2022.
Company raises the annual revenue guidance from mid-teens to high teens
We must try to make the health care system more accessible for people with disabilities
Besides enhancing workflow operations by connecting scientists with their lab instruments and data, digitalization holds the potential to acceleratee long-term business growth
Glenmark Pharmaceuticals announced its financial results for the fourth quarter ended March 31, 2022
The partnership aims to enhance HotSpot's drug discovery and development efforts by incorporating GOSTAR's high-quality, annotated datasets into HotSpot's machine learning (ML) and artificial intelligence (AI) models
The two companies will work together for the Prospective Evaluation of OrionAI – a revolutionary AI-based Diagnostic Assistant for Histological Examination of a variety of solid tumours beginning with Head and Neck Squamous Cell Carcinoma (HNSCC) Cancer
Subscribe To Our Newsletter & Stay Updated